Jan 11, 2019   SOURCE: PR NewsWire

Global $175 Mn Hemostasis Valve Market to 2023 - Key Players Include Boston Scientific, Abbott, Teleflex, B. Braun Melsungen, and Freudenberg Medical

DUBLIN, Jan. 11, 2019 /PRNewswire/ --

The "Hemostasis Valve Market by Type (Hemostasis Valve Y Connector, Double Y Connector Hemostasis Valve, One Handed), Application (Angioplasty, Angiography), End User (Hospitals), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The global hemostasis valves market is projected to reach USD 175.05 million by 2023 from USD 132.05 million in 2018, at a CAGR of 5.8% during the forecast period.

A hemostasis valve is used to reduce blood loss and optimize an interventional device during the interventional procedure. The hemostasis valve is made up of a plastic valve. The valve includes a lateral port for flushing and a seal at the proximal end which closes the catheter to prevent bleeding.

The growth in this market is attributed to the increasing number of interventional procedures. Emerging markets will be the key growth hotspots in the hemostasis valves market; a favorable market scenario in these countries will serve to attract a number of players to focus on opportunities there.

In this report, the market has been segmented by type, application, end user, and region. The hemostasis valves market is segmented into four major geographic segments - North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America is expected to command the largest share of 41.3% of the global hemostasis valves market, followed by Europe. The large share of the North American market is attributed to increasing number of interventional surgeries and rising geriatric population. The Asia Pacific market, on the other hand, is projected to register the highest growth in the forecast period.

Factors such as the increasing number of hospitals, growing population, and the increasing number of interventional procedures are driving the growth of the hemostasis valves market.

The major players operating in this market are Boston Scientific (US), Abbott (US), Teleflex Incorporated (US), B. Braun Melsungen (Germany), and Freudenberg Medical (US).

Key Topics Covered:

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.2 Primary Data
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Hemostasis Valves: Market Overview
4.2 North America: Hemostasis Valves Market, By Application (2018)
4.3 Geographical Snapshot of the Hemostasis Valves Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of Interventional Procedures
5.2.2 Opportunities
5.2.2.1 Emerging Economies
5.2.2.2 Growth in the Number of Hospitals

6 Hemostasis Valves Market, By Type
6.1 Introduction
6.2 Hemostasis Valve Y-Connectors
6.2.1 Hemostasis Valve Y-Connectors Segment to Account for the Largest Share of the Hemostasis Valves Market During the Forecast Period
6.3 Double Y-Connector Hemostasis Valves
6.3.1 Double Y-Connector Hemostasis Valves are the Fastest-Growing Segment of the One-Handed Hemostasis Valves Market
6.4 One-Handed Hemostasis Valves
6.4.1 Self-Closing Mechanism of One-Handed Hemostasis Valves to Drive Adoption
6.5 Other Hemostasis Valves

7 Hemostasis Valves Market, By Application
7.1 Introduction
7.2 Angiography
7.2.1 Increasing Number of Coronary Angiography Procedures to Drive Market Growth
7.3 Angioplasty
7.3.1 Increasing Burden of Coronary Heart Disease to Drive Market Growth

8 Hemostasis Valves Market, By End User
8.1 Introduction
8.2 Hospitals
8.2.1 Access to Advanced Facilities and Skilled Personnel is Driving Patient Preference for Hospital Care
8.3 Other End Users

9 Hemostasis Valves Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Rising Target Disease Incidence has Aided the Adoption of New Technologies in the Us
9.2.2 Canada
9.2.2.1 Increasing Number of Pci Procedures
9.3 Europe
9.3.1 Germany
9.3.1.1 Increasing Number of Intervention Procedures
9.3.2 UK
9.3.2.1 Rising Geriatric Population
9.3.3 France
9.3.3.1 Rising Geriatric Population
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.1.1 China Will Account for the Largest Share of the APAC Market
9.4.2 India
9.4.2.1 High Prevalence of Target Diseases Will Ensure Demand Growth in India
9.4.3 Japan
9.4.3.1 CVD Mortality has Decreased in the Country
9.4.4 Rest of Asia Pacific
9.5 Rest of the World

10 Competitive Landscape
10.1 Overview
10.2 Market Ranking Analysis, 2017
10.3 Competitive Scenario
10.3.1 Acquisitions
10.3.2 Expansions
10.3.3 Product Launches
10.3.4 Collaborations

11 Company Profiles

    --  Abbott
    --  Argon Medical
    --  B. Braun Melsungen AG
    --  Boston Scientific
    --  Deroyal Industries, Inc.
    --  Freudenberg Medical (A Subsidiary of Freudenberg Group)
    --  Merit Medical Systems
    --  Scitech
    --  Teleflex Incorporated
    --  Terumo

For more information about this report visit https://www.researchandmarkets.com/research/nh5cm3/global_175_mn?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-175-mn-hemostasis-valve-market-to-2023---key-players-include-boston-scientific-abbott-teleflex-b-braun-melsungen-and-freudenberg-medical-300776779.html

SOURCE Research and Markets